BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20260512T023803EDT-8089nf2dxF@132.216.98.100
DTSTAMP:20260512T063803Z
DESCRIPTION:“Advances in molecular diagnostics and new approaches in drug d
 iscovery” \n\nThe program will include speakers from Australia\, Germany\,
  United Kingdom\, United States and Canada.\n\nDay I will focus on molecul
 ar diagnostics with an emphasis on metabolomics. Topics:\n\nThe metabolic 
 legacy of SARS-CoV2 (Prof. Elaine Holmes\, Australia)\n	Metabolomics of car
 diometabolic diseases: potential markers of pre-morbidities for Covid-19 (
 Prof. Marc-Emmanuel Dumas\, United Kingdom)\n	NMR Based Tools for Clinical 
 and Translational Research (Dr. Manfred Spraul\, Bruker\, Germany)\n	Metabo
 lomics: from raw LC-MS spectra to biological insights (Prof. Jianguo (Jeff
 ) Xia\, �鶹��ý��վ\, Canada)\nDay II will focus on new approaches in drug disc
 overy and the FDA-approved Covid-19 drug remdesivir. Topics:\n\nEarly drug
  discovery in industry and drugging the cancer genome (Dr. Thomas Hudson\,
  Vice-President Abbvie USA & Prof. Vincent Mooser\, Canada Excellence Rese
 arch Chair in Genomic Medicine\, �鶹��ý��վ\, Canada)\n	Design of Proteolysis T
 argeting Chimera – PROTACs (Prof. Craig Crews\, Yale University\, USA)\n	Br
 eakthrough work on the Covid-19 remdesivir drug (Prof. Matthias Gö​tte\, U
 niversity of Alberta\, Canada)\n	Selected topics for trainee presentations.
 \nFor more info and registration\, click here.\n
DTSTART;VALUE=DATE:20201210
DTEND;VALUE=DATE:20201211
SUMMARY:VIth International Drug Discovery and Development Forum 
URL:/medhealthsci/channels/event/vith-international-dr
 ug-discovery-and-development-forum-326525
END:VEVENT
END:VCALENDAR